arrow
S

Shan Fu

The First Affiliated Hospital
H指数:23
被引数:1,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

CD19靶向和BCMA靶向CAR-T细胞的联合输注治疗难治性系统性红斑狼疮:一项1期临床试验

2025-09-240
PRE
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

自体人源化CD19 CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的安全性与有效性

2025-08-200
OAAI
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma

BCMA CAR-T细胞疗法在复发/难治性多发性骨髓瘤患者中的长期随访

2025-03-280
OA
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia

序贯CD19和CD22 CAR-T疗法在复发/难治性成人B细胞急性淋巴细胞白血病中表现出显著的疗效和良好的安全性。

2025-01-030
OA
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis

序贯CD7 CAR T细胞治疗和无GVHD预防的同种异体HSCT

2024-04-2517
PRE